Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;24(5):770-783.
doi: 10.1007/s12094-021-02735-1. Epub 2021 Nov 30.

Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH

J R Gonzalez-Porras  1 , J Mateo  2 , V Gonzalez-Calle  3 , P Marco  4 , V Garcia-Gutierrez  5 , J C Reverter  6 , R Lecumberri  7
Affiliations
Review

Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH

J R Gonzalez-Porras et al. Clin Transl Oncol. 2022 May.

Abstract

Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are scarce, limiting the development of evidence-based thromboprophylaxis guidelines. The present position paper is addressed to all hematologists treating patients affected by hematologic neoplasms with the aim to provide clinicians with a useful tool for the prevention of VTE.

Keywords: Deep-vein thrombosis; Hematologic neoplasms; Pulmonary embolism; Venous thrombosis.

PubMed Disclaimer

References

    1. Falanga A, Russo L, Milesi V, Vignoli A. Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol. 2017;118:79–83.
    1. Colombo R, Gallipoli P, Castelli R. Thrombosis and hemostatic abnormalities in hematological malignancies. Clin Lymphoma Myeloma Leuk. 2014;14:441–50.
    1. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111:4902–7.
    1. Ay C, Dunkler D, Marosi C, Chiriac A-L, Vormittag R, Simanek R, et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116:5377–82.
    1. Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med. 2012;7:291–2.

MeSH terms

LinkOut - more resources